World Journal of Dentistry

Register      Login

VOLUME 11 , ISSUE 1 ( January-February, 2020 ) > List of Articles


Anesthetic Success using Different Volumes of Articaine for Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis: A Randomized, Double-blind Study

Meetu Yadav, Mandeep S Grewal, Ashtha Arya, Anshul Arora, Gourav Thapak

Keywords : Articaine, Double volume, Inferior alveolar nerve block, Irreversible pulpitis

Citation Information : Yadav M, Grewal MS, Arya A, Arora A, Thapak G. Anesthetic Success using Different Volumes of Articaine for Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis: A Randomized, Double-blind Study. World J Dent 2020; 11 (1):12-16.

DOI: 10.5005/jp-journals-10015-1692

License: CC BY-NC 4.0

Published Online: 01-02-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Aim: The purpose of this study was to achieve maximum anesthetic success using different volumes of articaine as inferior alveolar nerve block (IANB) and ketorolac with/without buccal infiltration (BI) when treating molars with symptomatic irreversible pulpitis (IP). Materials and methods: A total of 160 mandibular molars with symptomatic IP randomly received conventional IANB either with one (1.8 mL) or two cartridges (3.6 mL) of 4% articaine after ketorolac oral premedication. Each group was further divided into two subgroups: one with BI with 1.8 mL articaine and the other with mock BI. Patients recorded their pain before and during access cavity preparation as well as during root canal instrumentation using a Heft–Parker visual analog scale (HP VAS). No or mild pain was considered as successful anesthesia. Results: A statistical analysis demonstrated that double-volume (3.6 mL) articaine and ketorolac with or without BI (87.5% and 80%, respectively) has a higher success rate when compared with single-volume (1.8 mL) articaine and ketorolac with and without BI (75% and 42%, respectively). Conclusion: Double-volume articaine with oral premedication and BI resulted in a significantly higher success rate when compared with singlevolume articaine and oral ketorolac premedication. The addition of BI to double/single-volume articaine IANB resulted in a higher success rate. Clinical significance: Double-volume articaine and infiltration with ketorolac premedication resulted in a higher success rate than single-volume articaine in mandibular teeth with IP.

  1. Daubländer M, Müller R, Lipp MD. The incidence of complications associated with local anaesthesia in dentistry. Anesth Prog 1997;44(4):132–141.
  2. Claffey E, Reader A, Nusstein J, et al. Anesthetic efficacy of articaine for inferior alveolar nerve blocks in patients with irreversible pulpitis. J Endod 2004;30(8):568–571. DOI: 10.1097/01. DON.0000125317.21892.8F.
  3. Ashraf H, Kazem M, Dianat O, et al. Efficacy of articaine versus lidocaine in block and infiltration anaesthesia administered in teeth with irreversible pulpitis: a prospective, randomized, double-blind study. J Endod 2013;39(1):6–10. DOI: 10.1016/j.joen.2012.10.012.
  4. Rogers BS, Botero TM, McDonald NJ, et al. Efficacy of articaine versus lidocaine as a supplemental buccal infiltration in mandibular molars with irreversible pulpitis: a prospective, randomized, double-blind study. J Endod 2014;40(6):753–758. DOI: 10.1016/j.joen.2013.12.022.
  5. Yadav M, Grewal MS, Grewal S, et al. Comparison of preoperative oral ketorolac on anaesthetic efficacy of inferior alveolar nerve block and buccal and lingual infiltration with articaine and lidocaine in patients with irreversible pulpitis: a prospective, randomized, controlled, double-blind study. J Endod 2015;41(11):1773–1777. DOI: 10.1016/j.joen.2015.06.008.
  6. Aggarwal V, Jain A, Kabi D. Anesthetic efficacy of supplemental buccal and lingual infiltrations of articaine and lidocaine after an inferior alveolar nerve block in patients with irreversible pulpitis. J Endod 2009;35(7):925–929. DOI: 10.1016/j.joen.2009. 04.012.
  7. Kanaa MD, Whitworth JM, Corbett IP, et al. Articaine and lidocaine mandibular buccal infiltration anesthesia: a prospective randomized double-blind cross-over study. J Endod 2006;32(4):296–298. DOI: 10.1016/j.joen.2005.09.016.
  8. A “3D” approach for treating acute pain. Endodontics: colleagues for excellence; winter; 2015. pp. 1–5.
  9. Chaudhary P, Martenson ME, Baumann TK. Vanilloid receptor expression and capsaicin excitation of rat dental primary af ferent neurons. J Dent Res 2001;80(6):1518–1523. DOI: 10.1177/00220345010800060801.
  10. Stenholm E, Bongenhielm U, Ahlquist M, et al. VRl- and VRL-l-like immunoreactivity in normal and injured trigeminal dental primary sensory neurons of the rat. Acta Odontol Scand 2002;60(2):72–79. DOI: 10.1080/000163502753509455.
  11. Goodis HE, Poon A, Hargreaves KM. Tissue pH and temperature regulate pulpal nociceptors. J Dent Res 2006;85(11):1046–1049. DOI: 10.1177/154405910608501114.
  12. Renton T, Yiangou Y, Baecker PA, et al. Capsaicin receptor VR1 and ATP purinoceptor P2X3 in painful and nonpainful human tooth pulp. J Orofac Pain 2003;3(17):245–250.
  13. Ferriera SH, Vane JR. New aspects of the mode of action of nonsteroidal anti-inflammatory drugs. Annu Rev Pharmacol 1974;14: 57–72. DOI: 10.1146/
  14. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995;75(2): 125–131. DOI: 10.1093/bja/75.2.125.
  15. Pogrel MA. Permanent nerve damage from inferior alveolar nerve blocks: a current update. J Calif Dent Assoc 2012;40(10):795–797.
  16. Oertel R, Rahn R, Kirch W. Clinical pharmacokinetics of articaine. Clin Pharm 1997;33(6):417–425. DOI: 10.2165/00003088-199733060-00002.
  17. Vree TB, Baars AM, van Oss GE, et al. High-performance liquid chromatography and preliminary pharmacokinetics of articaine and its 2-carboxy metabolite in human serum and urine. J Chromatogr 1998;424(2):440–444.
  18. Sood R, Hans MK, Shetty S. Comparison of anesthetic efficacy of 4% articaine with 1: 100,000 epinephrine and 2% lidocaine with 1:80,000 epinephrine for inferior alveolar nerve block in patients with irreversible pulpitis. J Clin Exp Dent 2014;6(5):e520–e523. DOI: 10.4317/jced.51617.
  19. Matthews R, Drum M, Reader A, et al. Articaine for supplemental buccal mandibular infiltration anesthesia in patients with irreversible pulpitis when the inferior alveolar nerve block fails. J Endod 2009;35(3):343–346. DOI: 10.1016/j.joen.2008.11.025.
  20. Kung J, McDonagh M, Sedgley CM. Does articaine provide an advantage over lidocaine in patients with symptomatic irreversible pulpitis? A systematic review and meta-analysis. J Endod 2015;41(11):1784–1794. DOI: 10.1016/j.joen.2015.07.001.
  21. Varrassi G, Marinangeli F, Agro F, et al. A double-blinded evaluation of propacetamol versus ketorolac in combination with patientcontrolled analgesia morphine: analgesic efficacy and tolerability after gynecologic surgery. Anesth Analg 1999;88(3):611–616. DOI: 10.1213/00000539-199903000-00028.
  22. McQuay HJ, Poppleton P, Carroll D, et al. Ketorolac and acetaminophen for orthopaedic postoperative pain. Clin Pharmacol Ther 1986;39(1):89–93. DOI: 10.1038/clpt.1986.15.
  23. Fletcher D, Negre I, Barbin C, et al. Postoperative analgesia with IV propacetamol and ketoprofen combination after disc surgery. Can J Anaesth 1997;44(5 Pt 1):479–485. DOI: 10.1007/BF03011934.
  24. Mroszczak E, Jung D, Yee J, et al. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy 1990;10(6(Pt 2)):33–49.
  25. Mishra H, Khan F. A double-blind, placebo-controlled randomized comparison of pre and postoperative administration of ketorolac and tramadol for extraction pain. J Anaesthesiol Clin Pharmacol 2012;28(2):221–225. DOI: 10.4103/0970-9185.94892.
  26. Johansson S, Josefsson G, Malstam J, et al. Analgesic efficacy and safety comparison of Ketorolac tromethamine and Doleron for the alleviation of orthopaedic postoperative pain. J Int Med Res 1989;17:324–332. DOI: 10.1177/030006058901700404.
  27. Management of acute pain, Endodontics, Colleagues for Excellence. Spring/Summer. American Association of Endodontics; 1995.
  28. Modaresi J, Dianat O, Mozayeni MA. The efficacy comparison of ibuprofen, acetaminophencodeine, and placebo premedication therapy on the depth of anesthesia during treatment of inflamed teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102(3):399–403. DOI: 10.1016/j.tripleo.2005.10.053.
  29. Ianiro SR, Jeansonne BG, McNeal SF, et al. The effect of preoperative acetaminophen or a conbination of acetaminophen and ibuprofen on the success of inferior alveolar nerve block for teeth with irreversible pulpitis. J Endod 2007;33(1):11–14. DOI: 10.1016/j.joen.2006.09.005.
  30. Aggarwal V, Singla M, Kabi D. Comparative evaluation of effect of preoperative oral medication of ibuprofen and ketorolac on anesthetic efficacy of inferior alveolar nerve block with lidocaine in patients with irreversible pulpitis: a prospective, double-blind, randomized clinical trial. J Endod 2010;36(3):445–449.
  31. Tortamano IP, Siviero M, Costa CG, et al. A comparison of the anesthetic efficacy of articaine and lidocaine in patients with irreversible pulpitis. J Endod 2009;35(2):165–168. DOI: 10.1016/j. joen.2008.10.020.
  32. Abazarpoor R, Parirokh M, Nakhaee N, et al. Comparison of different volumes of articaine for inferior alveolar nerve block for molar teeth with symptomatic irreversible pulpitis. J Endod 2015;41(9):1408–1411. DOI: 10.1016/j.joen.2015.05.015.
  33. Potocnik I, Bajrovic F. Failure of inferior alveolar nerve block in endodontics. Endod Dent Traumatol 1999;15(6):247–251. DOI: 10.1111/j.1600-9657.1999.tb00782.x.
  34. Haas DA, Lennon D. A 21 year retrospective study of reports of paresthesia following local anesthetic administration. J Can Dent Assoc 1995;61(4):319–320. , 323–326, 329–330.
  35. Malamed SF, Gagnon S, Leblanc D. Articaine hydrochloride: a study of the safety of a new amide local anesthetic. J Am Dent Assoc 2001;132(2):177–185. DOI: 10.14219/jada.archive.2001.0152.
  36. Malamed SF. Handbook of local anesthesia, 6th ed., St. Louis: Elsevier Mosby; 2013. p. 367.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.